Medicine’s focus has long been on treating specific diseases. We have radiation treatments to combat cancer tumors, cholesterol-lowering drugs to stave off heart attacks, andinsulin to control diabetes.
But imagine if there were a drug that would slow down the aging process itself, a drug that didn’t just treat a single disease but instead targeted multiple diseases of old age at once? It may sound far-fetched, but that’s precisely what longevity scientists are working hard to produce.
“It’s not just that we’re trying to make people live longer; we’re trying to make people live healthier. This is an exciting time for research,” says Felipe Sierra, director of the Division of Aging Biology at the National Institute on Aging.
Read full story:
USNews, May 2012